Madrigal Pharmaceuticals
MDGL
MDGL
136 hedge funds and large institutions have $1.01B invested in Madrigal Pharmaceuticals in 2018 Q4 according to their latest regulatory filings, with 22 funds opening new positions, 52 increasing their positions, 46 reducing their positions, and 42 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
less funds holding
Funds holding: →
45% less capital invested
Capital invested by funds: $1.85B → $1.01B (-$835M)
48% less first-time investments, than exits
New positions opened: 22 | Existing positions closed: 42
67% less funds holding in top 10
Funds holding in top 10: 3 → 1 (-2)
Holders
136
Holding in Top 10
1
Calls
$96.1M
Puts
$17M
Top Buyers
| 1 | +$48M | |
| 2 | +$43.8M | |
| 3 | +$19.4M | |
| 4 |
AllianceBernstein
Nashville,
Tennessee
|
+$10.5M |
| 5 |
FCM
Frontier Capital Management
Boston,
Massachusetts
|
+$9.45M |
Top Sellers
| 1 | -$27M | |
| 2 | -$26.8M | |
| 3 | -$20.5M | |
| 4 |
Victory Capital Management
San Antonio,
Texas
|
-$20.4M |
| 5 |
AC
Armistice Capital
New York
|
-$17.1M |